Gene · 1870
Papers2,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| JMJD6 functions as an oncogene and is associated with poor prognosis in esophageal squamous cell carcinoma. | BMC Cancer | 2023 | 37488513 | PubTator, text mining | PubMed |
| EHD1-dependent traffic of IGF-1 receptor to the cell surface is essential for Ewing sarcoma tumorigenesis and metastasis. | Commun Biol | 2023 | 37474760 | PubTator, text mining | PubMed |
| A deep learning-based framework for predicting survival-associated groups in colon cancer by integrating multi-omics and clinical data. | Heliyon | 2023 | 37455955 | PubTator, text mining | PubMed |
| Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies. | MedComm (2020) | 2023 | 37441462 | PubTator, text mining | PubMed |
| Pharmacological Activity of Flavonoid Quercetin and Its Therapeutic Potential in Testicular Injury. | Nutrients | 2023 | 37432408 | PubTator, text mining | PubMed |
| An in silico study to find potential effective circRNAs in the progression of Huntington's disease. | Iran J Basic Med Sci | 2023 | 37427327 | PubTator, text mining | PubMed |
| A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanoma. | Cancer Gene Ther | 2023 | 37420093 | PubTator, text mining | PubMed |
| Beta cell dysfunction induced by bone morphogenetic protein (BMP)-2 is associated with histone modifications and decreased NeuroD1 chromatin binding. | Cell Death Dis | 2023 | 37407581 | PubTator, text mining | PubMed |
| Hallmark guided identification and characterization of a novel immune-relevant signature for prognostication of recurrence in stage I-III lung adenocarcinoma. | Genes Dis | 2023 | 37397559 | PubTator, text mining | PubMed |
| A Bibliometric Analysis of Exosomes Therapy in the Treatment of Osteoarthritis from 2012 to 2022. | J Pain Res | 2023 | 37397273 | PubTator, text mining | PubMed |
| UBE2C expression is elevated in hepatoblastoma and correlates with inferior patient survival. | Front Genet | 2023 | 37377594 | PubTator, text mining | PubMed |
| Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer. | Int J Mol Sci | 2023 | 37373139 | PubTator, text mining | PubMed |
| Foreword Special Issue Genomic Instability in Tumor Evolution and Therapy Response. | Cancers (Basel) | 2023 | 37370691 | PubTator, text mining | PubMed |
| E2F2 modulates cell adhesion through the transcriptional regulation of PECAM1 in multiple myeloma. | Br J Haematol | 2023 | 37365680 | PubTator, text mining | PubMed |
| Resistance mechanism to Notch inhibition and combination therapy in human T-cell acute lymphoblastic leukemia. | Blood Adv | 2023 | 37358480 | PubTator, text mining | PubMed |
| Diosmetin suppresses the progression of ESCC by CDK2/Rb/E2F2/RRM2 pathway and synergies with cisplatin. | Oncogene | 2023 | 37349644 | PubTator, text mining | PubMed |
| ATR kinase supports normal proliferation in the early S phase by preventing replication resource exhaustion. | Nat Commun | 2023 | 37336885 | PubTator, text mining | PubMed |
| Integrated analysis of circRNA-associated ceRNA network in ischemic stroke. | Front Genet | 2023 | 37323662 | PubTator, text mining | PubMed |
| LINC00886 Facilitates Hepatocellular Carcinoma Tumorigenesis by Sequestering microRNA-409-3p and microRNA-214-5p. | J Hepatocell Carcinoma | 2023 | 37313303 | PubTator, text mining | PubMed |
| Targeting CDK1 in cancer: mechanisms and implications. | NPJ Precis Oncol | 2023 | 37311884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1870/papers?page=12